publicações selecionadas
-
artigo académico
- Darifenacin: a promising chitinase 3-like 1 inhibitor to tackle drug resistance in pancreatic ductal adenocarcinoma. Cancer Chemotherapy and Pharmacology. 2024
-
documento
- Chitinase 3-like-1 identified in large extracellular vesicles from human macrophages: a promising therapeutic drug target for pancreatic cancer (Best Poster Award in the session I of EVs in Cancer) 2023
- Darifenacin as novel chemosensitizer in pancreatic cancer 2023
- Efeito sensibilizador da darifenacina a agentes citotóxicos no cancro pancreático: estudo in silico e em linhas celulares 2022
- Targeting Chitinase-like-1 (CHI3L1) as a therapeutic target for pancreatic cancer 2021